Leman Biotech vs Moleculent
Leman Biotech vs Moleculent, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Leman Biotech is on 48/100 and Moleculent on 61/100.
Where each one leads
Leman Biotech
Leads on none of the measures we hold for both companies.
Moleculent
- our overall score: 61/100 against 48/100
- agent readiness: 47/100 against 20/100
- funding raised: $46.0M against $22.7M
At a glance
| Measure | Leman Biotech | Moleculent |
|---|---|---|
| What it is | Clinical-stage biotech developing AI-driven metabolic immunotherapies for cancer and autoimmune diseases. | Mapping cell-cell communication at scale in human tissue. |
| Category | Biotech, HealthTech, Drug Discovery, Immunotherapy | Biotech, Life Sciences, Genomics, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2021 | 2019 |
| Headquarters | Shenzhen, China | Stockholm, Sweden |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Leman Biotech | Moleculent |
|---|---|---|
| Employees | Not published | 64 |
| Total funding | $22.7M | $46.0M |
| Latest round | Series A | Series B |
| LinkedIn followers | Not published | 345 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Leman Biotech | Moleculent |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 48/100 | 61/100 |
| Traction | 37/100 | 56/100 |
| Team | 60/100 | 70/100 |
| Search visibility | 18/100 | 37/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (20/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | Not published | 36/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Leman Biotech | Moleculent |
|---|---|---|
| Hosting | Not detected | AWS |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Tailwind CSS |
| Analytics | Not detected | Google Tag Manager |
| Support stack | Not detected | HubSpot |
Leman Biotech vs Moleculent: common questions
Which is better, Leman Biotech or Moleculent?
On our 0-100 score Moleculent rates higher (61/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Leman Biotech and Moleculent compare on the numbers?
Moleculent leads on our overall score (61/100 against 48/100), agent readiness (47/100 against 20/100), funding raised ($46.0M against $22.7M).
Read the full Leman Biotech review and pricing or the Moleculent review and pricing. You can also browse other Leman Biotech alternatives we track.